Verastem, Inc. (31)
Browse by Contract Category
Contracts
-
Purchase Agreement, dated as of January 24, 2023, among Verastem, Inc. and each purchaser party thereto
(Filed With SEC on January 25, 2023)
-
Section 203 Agreement entered into as of March 28, 2022 by and between Baker Bros. Advisors LP and Verastem, Inc
(Filed With SEC on March 30, 2022)
-
Form of Restricted Stock Unit Agreement under the 2021 Equity Incentive Plan
(Filed With SEC on August 2, 2021)
-
License Agreement for CKI27, dated January 7, 2020, between Verastem, Inc. and Chugai Pharmaceutical Co., Ltd
(Filed With SEC on May 7, 2020)
-
License and Collaboration Agreement, dated July 25, 2019, between Verastem, Inc. and Sanofi
(Filed With SEC on October 30, 2019)
-
Exchange Agreement, dated November 4, 2022, by and among Verastem, Inc. and the Stockholders named therein
(Filed With SEC on November 7, 2022)
-
Loan and Security Agreement, dated as of March 25, 2022, among Verastem, Inc., as borrower, Oxford Finance LLC, as collateral agent and a lender, and Oxford Finance Credit Fund...
(Filed With SEC on March 28, 2022)
-
Description of Securities
(Filed With SEC on March 28, 2022)
-
Form of Inducement Restricted Stock Unit Agreement
(Filed With SEC on August 2, 2021)
-
Form of Inducement Nonstatutory Stock Option Agreement
(Filed With SEC on August 2, 2021)
-
Form of Nonstatutory Stock Option Agreement (Non-Employees) under the 2021 Equity Incentive Plan
(Filed With SEC on August 2, 2021)
-
Form of Nonstatutory Stock Option Agreement (Employees) under the 2021 Equity Incentive Plan
(Filed With SEC on August 2, 2021)
-
Form of Incentive Stock Option Agreement under the 2021 Equity Incentive Plan
(Filed With SEC on August 2, 2021)
-
Description of Securities
(Filed With SEC on March 18, 2021)
-
Form of Second Supplemental Indenture, by and between the Company and Wilmington Trust, National Association
(Filed With SEC on November 9, 2020)
-
Exchange Agreement by and between Verastem, Inc. and Highbridge Tactical Credit Master Fund, L.P., dated November 6, 2020
(Filed With SEC on November 9, 2020)
-
Asset Purchase Agreement by and between Secura Bio, Inc. and Verastem, Inc
(Filed With SEC on November 9, 2020)
-
Verastem, Inc. Amended and Restated 2012 Incentive Plan
(Filed With SEC on May 21, 2020)
-
Form of Inducement Nonstatutory Stock Option Agreement
(Filed With SEC on May 7, 2020)
-
Form of Nonstatutory Stock Option Agreement under 2012 Incentive Plan
(Filed With SEC on May 7, 2020)
-
Form of Incentive Stock Option Agreement under 2012 Incentive Plan
(Filed With SEC on May 7, 2020)
-
Form of Inducement Restricted Stock Unit Agreement
(Filed With SEC on May 7, 2020)
-
Form of Restricted Stock Unit Agreement under the 2012 Incentive Plan
(Filed With SEC on May 7, 2020)
-
Consulting Agreement, dated June 27, 2019, between Joseph Lobacki and Verastem, Inc
(Filed With SEC on March 11, 2020)
-
Separation Agreement, dated June 25, 2019, between Robert Forrester and Verastem, Inc
(Filed With SEC on March 11, 2020)
-
Consulting Agreement, dated June 21, 2019, between Robert Forrester and Verastem, Inc
(Filed With SEC on March 11, 2020)
-
Description of Securities
(Filed With SEC on March 11, 2020)
-
Purchase Agreement, dated as of February 27, 2020, among Verastem, Inc. and each purchaser party thereto
(Filed With SEC on February 28, 2020)
-
Form of Exchange Agreement, dated as of November 12, 2019, among Verastem, Inc. and each investor party thereto
(Filed With SEC on November 12, 2019)
-
Employment Agreement, dated July 29, 2019, by and between Verastem, Inc. and Brian M. Stuglik
(Filed With SEC on August 1, 2019)
-
Fourth Amendment to the Loan and Security Agreement, as amended, with Hercules Capital Inc., as administrative agent, and the Lenders from time to time party thereto
(Filed With SEC on April 23, 2019)